Authors:
Barrow, JC
Nantermet, PG
Selnick, HG
Glass, KL
Ngo, PL
Young, MB
Pellicore, JM
Breslin, MJ
Hutchinson, JH
Freidinger, RM
Condra, C
Karczewski, J
Bednar, RA
Gaul, SL
Stern, A
Gould, R
Connolly, TM
Citation: Jc. Barrow et al., Discovery and initial structure-activity relationships of trisubstituted ureas as thrombin receptor (PAR-1) antagonists, BIOORG MED, 11(20), 2001, pp. 2691-2696
Authors:
Garsky, VM
Lumma, PK
Feng, DM
Wai, J
Ramjit, HG
Sardana, MK
Oliff, A
Jones, RE
DeFeo-Jones, D
Freidinger, RM
Citation: Vm. Garsky et al., The synthesis of a prodrug of doxorubicin designed to provide reduced systemic toxicity and greater target efficacy, J MED CHEM, 44(24), 2001, pp. 4216-4224
Authors:
Barrow, JC
Glass, KL
Selnick, HG
Freidinger, RM
Chang, RSL
O'Malley, SS
Woyden, C
Citation: Jc. Barrow et al., Preparation and evaluation of 1,3-diaminocyclopentane-linked dihydropyrimidinone derivatives as selective alpha(1a)-receptor antagonists, BIOORG MED, 10(17), 2000, pp. 1917-1920
Authors:
Nantermet, PG
Barrow, JC
Selnick, HG
Homnick, CF
Freidinger, RM
Chang, RSL
O'Malley, SS
Reiss, DR
Broten, TP
Ransom, RW
Pettibone, DJ
Olah, T
Forray, C
Citation: Pg. Nantermet et al., Selective alpha(1a) adrenergic receptor antagonists based on 4-aryl-3,4-dihydropyridine-2-ones, BIOORG MED, 10(15), 2000, pp. 1625-1628
Authors:
Barrow, JC
Nantermet, PG
Selnick, HG
Glass, KL
Rittle, KE
Gilbert, KF
Steele, TG
Homnick, CF
Freidinger, RM
Ransom, RW
Kling, P
Reiss, D
Broten, TP
Schorn, TW
Chang, RSL
O'Malley, SS
Olah, TV
Ellis, JD
Barrish, A
Kassahun, K
Leppert, P
Nagarathnam, D
Forray, C
Citation: Jc. Barrow et al., In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective alpha(1A) receptor antagonists for the treatment of benign prostatic hyperplasia, J MED CHEM, 43(14), 2000, pp. 2703-2718
Authors:
Williams, PD
Bock, MG
Evans, BE
Freidinger, RM
Gallicchio, SN
Guidotti, MT
Jacobson, MA
Kuo, MS
Levy, MR
Lis, EV
Michelson, SR
Pawluczyk, JM
Perlow, DS
Pettibone, DJ
Quigley, AG
Reiss, DR
Salvatore, C
Stauffer, KJ
Woyden, CJ
Citation: Pd. Williams et al., Nonpeptide oxytocin antagonists: Analogs of L-371,257 with improved potency, BIOORG MED, 9(9), 1999, pp. 1311-1316
Authors:
Dhar, TGM
Nagarathnam, D
Marzabadi, MR
Lagu, B
Wong, WC
Chiu, G
Tyagarajan, S
Miao, SW
Zhang, FQ
Sun, WY
Tian, D
Shen, QR
Zhang, J
Wetzel, JM
Forray, C
Chang, RSL
Broten, TP
Schorn, TW
Chen, TB
O'Malley, S
Ransom, R
Schneck, K
Bendesky, R
Harrell, CM
Vyas, KP
Zhang, KY
Gilbert, J
Pettibone, DJ
Patane, MA
Bock, MG
Freidinger, RM
Gluchowski, C
Citation: Tgm. Dhar et al., Design and synthesis of novel alpha(1a) adrenoceptor-selective antagonists. 2. Approaches to eliminate opioid agonist metabolites via modification oflinker and 4-methoxycarbonyl-4-phenylpiperidine moiety, J MED CHEM, 42(23), 1999, pp. 4778-4793